Daniel S. Lorrain serves as Executive at Contineum Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Daniel S. Lorrain has executed 1 insider transactions totaling $51.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 23, 2025 involved selling 4,170 shares valued at $51.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 23, 2025 | CTNM | $51.0K | Sale | 4,170 | $12.23 | Discretionary |
Daniel S. Lorrain currently holds 164,392 shares of Contineum Therapeutics, Inc. (CTNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel S. Lorrain has been a net seller of CTNM stock. They have purchased $0 and sold $51.0K worth of shares.
Daniel S. Lorrain's most recent insider trade was on Dec 23, 2025, when they sold 4,170 shares at $12.23 per share.
Get notified when new Form 4 filings are submitted